We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Full Fed. Circ. Asked To Skip 'Blocking Patent' Case

Law360 (November 28, 2018, 5:50 PM EST) -- Generics makers Roxane and Teva urged the full Federal Circuit Tuesday not to rehear a decision invalidating four Acorda patents on the multiple sclerosis drug Ampyra, arguing that the ruling was...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.